Citius Pharmaceuticals, Inc. (CTXR)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
0. 50
-0.01
-2.9354%
$
6.51M Market Cap
- P/E Ratio
- Div Yield
285,400 Volume
0.03 Eps
$ 0.51
Previous Close 
Want to track CTXR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is Citius Pharmaceuticals (CTXR) Stock Up 11% Today?
Citius Pharmaceuticals (NASDAQ: CTXR ) stock is on the rise Tuesday after the company announced new results from its Phase 3 clinical trial of Mino-Lok. Mino-Lok is Citius Pharmaceuticals' antibiotic lock solution for patients with central line-associated infections or catheter-related bloodstream infections.
Investorplace | 2 years ago
